Cleveland Clinic’s Top 10 list of breakthrough technologies for the coming year has become an international sensation.
Reimbursement strategies for genomic innovation.
A pharma perspective.
The threat of soaring drug costs.
Macroeconomic pressures have hit the R&D returns of life sciences firms.